180 LIFE SCIENCES CORP. - Annual Financials - Cash Flow (SEC)

Updated on January 3, 2026.

Related Topics: SEC Topic List.

Data Source: SEC.

See details in table below.

You can see similar for other companies.

180 LIFE SCIENCES CORP. - Annual Cash Flow (In Thousands of USD, Except Per Share Amounts)

Breakdown	2024-12-31	2023-12-31	2022-12-31
Net Loss	0	0
Stock-based compensation	0	0
Shares issued for services	0	89.189
Amortization of stock options and restricted stock units	308.169	2194.135
Depreciation and amortization	58.277	105.675
Loss on asset impairment	-1526.542	-9063
Change in fair value of derivative liabilities	-0.058	-75.323
Change in fair value of preferred stock liability	1577.305	0
Gain on settlement of liabilities	222.802	0
Deferred tax benefit	-292.417	-2349.683
Prepaid expenses and other current assets	-1874.958	-337.282
Accounts payable	-243.524	230.402
Accounts payable - related parties	417.273	56.008
Accrued expenses	-316.113	-440.621
Accrued expenses - related parties	0	-197.175
Total adjustments	4687.61	9012.889
Net Cash Used In Operating Activities	-1480.567	-10922.223
Proceeds from exercise of pre-funded warrants from the Amendment to August 2023 Offering	0.489	0
Proceeds from sale of December 2024 Offering stock and warrants	2572.789	0
Proceeds from the exercise of warrants	2797.936	0
Proceeds from sale of April 2023 Offering stock and warrants	0	2999.882
Proceeds from sale of August 2023 Offering stock and warrants	0	2999.606
Proceeds from exercise of April 2023 Offering pre-funded warrants	0	0.117
Proceeds from exercise of August 2023 Offering pre-funded warrants	0	0.395
Proceeds from the repricing of common shares and pre-funded warrants in the August 2023 Offering	0	830.769
Proceeds from loans payable	0	969.322
Payment of offering costs in connection with April 2023 Offering stock and warrants	0	-279.994
Payment of offering costs in connection with August 2023 Offering stock and warrants	0	-294.976
Payment of offering costs in connection with August 2023 sale of common stock and common stock warrants	0	59.846
Repayment of loans payable	1333.499	1257.388
Net cash provided by financing activities	4037.715	5907.887
Effect of Exchange Rate Changes on Cash	52.194	20.025
Net Decrease In Cash	2609.342	-4994.311
Cash - Beginning of Period	4585.141	1975.799	6970.11
Cash - End of Period	4585.141	1975.799	6970.11
Cash paid during the period for income taxes	0	0
Cash paid during the period for interest expense	12.078	21.722
Common stock issued for settlement of liabilities	684.671	0
Prepaid expense financed with notes payable	777.702	0
Warrants and Series B Convertible Preferred Stock issued for asset acquisition	7622.041	0
Deemed dividend from warrant inducement	8011.51	0